Aims & scope
Aim
The Journal of Pharmacy and Intelligent Therapeutics is an international, peer-reviewed journal dedicated to advancing pharmaceutical sciences, pharmacy practice, and intelligent therapeutic approaches through innovative research and evidence-based scientific contributions. The journal aims to provide a multidisciplinary platform for researchers, academicians, healthcare professionals, pharmacists, and industry experts to share developments that enhance drug discovery, pharmaceutical development, medication management, therapeutic outcomes, and patient care.
The journal encourages research that bridges traditional pharmaceutical sciences with emerging technologies, including artificial intelligence, machine learning, computational methods, digital health, and data-driven therapeutic strategies. It seeks to promote scientific knowledge that supports the development of safer, more effective, accessible, and personalized medicines while addressing contemporary challenges in pharmaceutical research and clinical practice.
Scope
The journal welcomes original research articles, review articles, systematic reviews, case reports, short communications, and perspectives covering a broad range of pharmaceutical and therapeutic disciplines, including but not limited to:
Pharmaceutical Sciences and Drug Development: Drug discovery, medicinal chemistry, pharmaceutical formulation, preformulation studies, drug delivery systems, nanopharmaceuticals, biopharmaceutical development, and pharmaceutical technology.
Intelligent and AI-Driven Pharmacy: Applications of artificial intelligence, machine learning, deep learning, computational modeling, and predictive analytics in drug discovery, formulation optimization, medication management, therapeutic decision-making, and pharmaceutical research.
Clinical Pharmacy and Therapeutic Practice: Clinical pharmacy services, medication optimization, pharmaceutical care, clinical decision support, drug utilization evaluation, medication reconciliation, and evidence-based therapeutic interventions.
Pharmacology and Therapeutics: Experimental and clinical pharmacology, pharmacodynamics, pharmacokinetics, pharmacogenomics, drug interactions, therapeutic drug monitoring, and the evaluation of drug efficacy and safety.
Pharmacovigilance and Drug Safety: Adverse drug reaction monitoring, medication error prevention, signal detection, risk assessment, post-marketing surveillance, and AI-enabled approaches to drug safety evaluation.
Precision and Personalized Medicine: Individualized drug therapy, pharmacogenomics-guided treatment, biomarker-driven therapeutic approaches, precision dosing, and personalized medication management.
Digital Pharmacy and Healthcare Technologies: Digital therapeutics, telepharmacy, smart medication systems, electronic prescribing, digital medication adherence tools, and technology-enabled pharmaceutical care.
Pharmaceutical Biotechnology and Biotherapeutics: Biologics, biosimilars, therapeutic proteins, gene and cell-based therapies, vaccine development, and emerging biopharmaceutical technologies.
Pharmaceutical Regulatory Science and Policy: Drug approval pathways, regulatory harmonization, pharmaceutical quality standards, regulatory intelligence, and the role of emerging technologies in pharmaceutical regulation.
Pharmacoepidemiology and Real-World Evidence: Drug utilization research, real-world safety and effectiveness, comparative effectiveness studies, medication adherence, and evidence generation from healthcare databases.
Pharmacy Practice, Access, and Health Systems: Community and hospital pharmacy, pharmacy education, medication access, pharmaceutical economics, healthcare delivery models, and the integration of intelligent technologies into pharmacy services.
Emerging Therapeutic Strategies: Novel drug targets, combination therapies, targeted drug delivery, advanced therapeutic approaches, and innovative treatment strategies addressing unmet medical needs.
The journal particularly encourages interdisciplinary research that integrates pharmaceutical sciences, clinical practice, computational technologies, and therapeutic innovation. By fostering collaboration across academia, healthcare, and the pharmaceutical industry, the Journal of Pharmacy and Intelligent Therapeutics aims to contribute to the advancement of pharmaceutical knowledge and the development of intelligent, patient-centered therapeutic solutions.
The journal welcomes scientifically rigorous and ethically conducted research that demonstrates originality, methodological quality, and meaningful contributions to pharmaceutical science, intelligent therapeutics, and clinical healthcare.
Latest publications
No published articles yet
New research will appear here as issues are published.